doi: 10.1016/j.bmcl.2006.01.007.
Epub 2006 Jan 24.
Synthesis and activity of small molecule GPR40 agonists
Affiliations
- PMID: 16439116
- DOI: 10.1016/j.bmcl.2006.01.007
Item in Clipboard
Synthesis and activity of small molecule GPR40 agonists
Bioorg Med Chem Lett.
.
Abstract
The first report on the identification and structure-activity relationships of a novel series of GPR40 agonists based on a 3-(4-{[N-alkyl]amino}phenyl)propanoic acid template is described. Structural modifications to the original screening hit yielded compounds with a 100-fold increase in potency at the human GPR40 receptor and pEC(50)s in the low nanomolar range. The carboxylic acid moiety is not critical for activity but typically elicits an agonistic response higher than those observed with carboxamide replacements. These compounds may prove useful in unraveling the therapeutic potential of this receptor for the treatment of Type 2 diabetes.
Similar articles
-
Progress in the discovery and development of small-molecule modulators of G-protein-coupled receptor 40 (GPR40/FFA1/FFAR1): an emerging target for type 2 diabetes.Expert Opin Ther Pat. 2009 Feb;19(2):237-64. doi: 10.1517/13543770802665717. Expert Opin Ther Pat. 2009. PMID: 19441920 Review.
-
Discovery of diacylphloroglucinols as a new class of GPR40 (FFAR1) agonists.Bioorg Med Chem Lett. 2008 Dec 15;18(24):6357-61. doi: 10.1016/j.bmcl.2008.10.085. Epub 2008 Nov 1. Bioorg Med Chem Lett. 2008. PMID: 18993064
-
Design, synthesis, and biological activity of potent and orally available G protein-coupled receptor 40 agonists.J Med Chem. 2011 Mar 10;54(5):1365-78. doi: 10.1021/jm101405t. Epub 2011 Feb 14. J Med Chem. 2011. PMID: 21319751
-
Solid phase synthesis and SAR of small molecule agonists for the GPR40 receptor.Bioorg Med Chem Lett. 2007 Mar 15;17(6):1584-9. doi: 10.1016/j.bmcl.2006.12.084. Epub 2007 Jan 4. Bioorg Med Chem Lett. 2007. PMID: 17240142
-
Nonpeptide Urotensin-II receptor agonists and antagonists: review and structure-activity relationships.Peptides. 2008 May;29(5):680-90. doi: 10.1016/j.peptides.2007.09.019. Epub 2007 Oct 6. Peptides. 2008. PMID: 18022732 Review.
Cited by
-
Evidence for NADPH oxidase activation by GPR40 in pancreatic β-cells.Redox Rep. 2020 Dec;25(1):41-50. doi: 10.1080/13510002.2020.1757877. Redox Rep. 2020. PMID: 32354273 Free PMC article.
-
Lipotoxicity and β-Cell Failure in Type 2 Diabetes: Oxidative Stress Linked to NADPH Oxidase and ER Stress.Cells. 2021 Nov 26;10(12):3328. doi: 10.3390/cells10123328. Cells. 2021. PMID: 34943836 Free PMC article. Review.
-
G protein-coupled receptors for energy metabolites as new therapeutic targets.Nat Rev Drug Discov. 2012 Aug;11(8):603-19. doi: 10.1038/nrd3777. Epub 2012 Jul 13. Nat Rev Drug Discov. 2012. PMID: 22790105 Review.
-
Discovery and Optimization of Potent GPR40 Full Agonists Containing Tricyclic Spirocycles.ACS Med Chem Lett. 2013 May 7;4(6):551-5. doi: 10.1021/ml300427u. eCollection 2013 Jun 13. ACS Med Chem Lett. 2013. PMID: 24900707 Free PMC article.
-
FFA1-selective agonistic activity based on docking simulation using FFA1 and GPR120 homology models.Br J Pharmacol. 2013 Apr;168(7):1570-83. doi: 10.1111/j.1476-5381.2012.02052.x. Br J Pharmacol. 2013. PMID: 22639973 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Molecular Biology Databases
